Literature DB >> 27133553

Label-free analysis of GPCR-stimulation: The critical impact of cell adhesion.

S Lieb1, S Michaelis2, N Plank1, G Bernhardt1, A Buschauer1, J Wegener3.   

Abstract

Label-free cell-based assays have been attracting growing attention in drug research. Optical approaches based on evanescent electric fields (e.g. EPIC, RWG/DMR, SPR) and electrochemical impedance analysis (ECIS, xCELLigence) are by far the most widespread techniques for such purposes. We compared three label-free approaches (ECIS, RWG/DMR and SPR) with respect to the activation of the human histamine H1 receptor (H1R) expressed by U-373 MG glioblastoma and genetically engineered HEK 293T cells. HEK 293T cells were either expressing the hH1R alone or in combination with the adhesion protein hMSR1. The β2-adrenergic receptor (β2-AR) expressed by bovine aortic endothelial cells (BAEC) served as a second cell model. Reduced cell adhesion to the surface of the sensing devices affected both, the optical and the impedance-based readout, but became much more obvious in case of RWG- or SPR-based assays. By contrast, the co-expression of hH1R and hMSR1 in HEK 293T cells strongly enhanced the signal compared to hH1R expression alone. As the sensitivity of the optical readouts is confined to a distance of 100-200nm from the surface, depending on the wavelength of the incident light, this observation is in accordance with tighter adhesion of the co-transfectants, inducing a shorter distance between the cell membrane and the substrate. Combining ECIS and SPR, allowing for simultaneous registration of both signals for a single cell population, provided a direct correlation of both readouts, when H1R or β2-AR stimulation was investigated for the same cell populations. Cell adhesion was found to have a critical impact on the results of label-free cell monitoring, in particular when techniques based on evanescent electric fields are applied.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  Cell-based assays; Dynamic mass redistribution (DMR); ECIS; G-protein-coupled receptors; Holistic; Label-free; SPR

Mesh:

Substances:

Year:  2016        PMID: 27133553     DOI: 10.1016/j.phrs.2016.04.026

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  7 in total

Review 1.  Impedance-based cellular assays for regenerative medicine.

Authors:  W Gamal; H Wu; I Underwood; J Jia; S Smith; P O Bagnaninchi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-07-05       Impact factor: 6.237

2.  Investigating the ligand agonism and antagonism at the D2long receptor by dynamic mass redistribution.

Authors:  Lisa Forster; Steffen Pockes
Journal:  Sci Rep       Date:  2022-06-10       Impact factor: 4.996

3.  Probing the Drug Dynamics of Chemotherapeutics Using Metasurface-Enhanced Infrared Reflection Spectroscopy of Live Cells.

Authors:  Po-Ting Shen; Steven H Huang; Zhouyang Huang; Justin J Wilson; Gennady Shvets
Journal:  Cells       Date:  2022-05-10       Impact factor: 7.666

4.  Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies.

Authors:  Chiara Ruzza; Federica Ferrari; Remo Guerrini; Erika Marzola; Delia Preti; Rainer K Reinscheid; Girolamo Calo
Journal:  Pharmacol Res Perspect       Date:  2018-12-03

5.  Label-free detection of transporter activity via GPCR signalling in living cells: A case for SLC29A1, the equilibrative nucleoside transporter 1.

Authors:  Anna Vlachodimou; Adriaan P IJzerman; Laura H Heitman
Journal:  Sci Rep       Date:  2019-09-24       Impact factor: 4.379

6.  NOP receptor pharmacological profile - A dynamic mass redistribution study.

Authors:  Davide Malfacini; Katharina Simon; Claudio Trapella; Remo Guerrini; Nurulain T Zaveri; Evi Kostenis; Girolamo Calo'
Journal:  PLoS One       Date:  2018-08-30       Impact factor: 3.240

7.  BRET-Based Biosensors to Measure Agonist Efficacies in Histamine H1 Receptor-Mediated G Protein Activation, Signaling and Interactions with GRKs and β-Arrestins.

Authors:  Eléonore W E Verweij; Reggie Bosma; Meichun Gao; Jelle van den Bor; Betty Al Araaj; Sabrina M de Munnik; Xiaoyuan Ma; Rob Leurs; Henry F Vischer
Journal:  Int J Mol Sci       Date:  2022-03-16       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.